Ketonal (Ketoprofen)

Ketoprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain signaling, and swelling at the site where the gel or cream is applied.

The appropriate dose of Ketonal is determined by the prescribing healthcare professional based on the patient’s condition, age, and response. The prescriber will specify the amount to apply, frequency, and duration of treatment on the product label or prescription.

Safety data for topical ketoprofen in pregnancy and lactation are limited. Because systemic absorption can occur, it is generally advised to avoid use unless the potential benefit outweighs the risk, and only under medical supervision.

To request Ketonal, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ketonal, as a topical ketoprofen formulation, delivers the anti‑inflammatory effect directly to the skin, potentially reducing systemic exposure compared with oral NSAIDs. This can lower the risk of gastrointestinal and cardiovascular side effects, though local skin reactions may be more common.

Ketonal should be stored at room temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperatures to maintain product stability and potency.

Ketonal is applied topically to clean, dry skin over the painful or inflamed area. The prescriber will advise the amount (e.g., a thin film or specific pea‑size amount) and frequency, typically 2‑4 times daily, avoiding broken skin or mucous membranes.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, liver toxicity, kidney impairment, gastrointestinal ulceration or bleeding, and increased cardiovascular events. Patients should seek immediate medical attention if they experience signs of these conditions.

Ketonal should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, those with active gastrointestinal ulcers, severe liver or kidney disease, and patients on anticoagulant therapy where bleeding risk is high, unless a healthcare professional determines it is safe.